{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T03:27:25Z","timestamp":1786591645138,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100022661","name":"European Brain Council","doi-asserted-by":"publisher","award":["551578"],"award-info":[{"award-number":["551578"]}],"id":[{"id":"10.13039\/501100022661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals U.S.A.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]},{"name":"REATA Pharmaceuticals"},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N028767\/1"],"award-info":[{"award-number":["MR\/N028767\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The ataxias are rare complex neurological disorders challenging for clinicians to manage. The costs of ataxia care and differences in healthcare use and treatment outcomes between specialised ataxia centres (SAC) and standard neurology services have not been investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study explored patient pathways, healthcare use and costs, comparing SAC with non\u2013specialist settings in Italy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A patient survey was distributed in Italy (May\u2013September 2021) to collect information about the diagnosis and management of ataxias in SAC and non-specialist settings, healthcare service visits, and patients\u2019 satisfaction. We compared per-patient mean resource use for each contact type and health service cost, stratifying patients by SAC attendance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 174 participants, 44% saw a neurologist within 6\u00a0months of seeking medical advice, and 56% went to a SAC directly. Travelling was a top reason why people stopped going to a SAC and a barrier preventing patients from accessing it. SACs delivered better service to patients in various aspects of care. The differences in the number of contacts for various health services between the SAC and non-SAC groups were mostly non-significant. The mean total cost per patient over a one-year period was \u20ac1952 for non-SAC and \u20ac1666 for SAC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>There was a trend towards patients\u2019 appreciation for SAC services compared with non-SAC services, without significant change in costs. We identified difficulties in attendance and adherence despite the significant number of SACs in Italy. We believe that the combination of face-to-face and telemedicine could improve patients\u2019 attendance at SACs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10072-026-09150-w","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:51:39Z","timestamp":1784184699000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ataxia patient care pathway and associated healthcare costs in Italy: a cross-sectional survey"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2092-5073","authenticated-orcid":false,"given":"Julie","family":"Vallortigara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Greenfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Filla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Federico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Litani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Giunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"issue":"4 Movement Diso","key":"9150_CR1","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1212\/CON.0000000000000362","volume":"22","author":"T Ashizawa","year":"2016","unstructured":"Ashizawa T, Xia G (2016) Ataxia. Continuum (Minneap Minn) 22(4 Movement Disorders):1208\u20131226. https:\/\/doi.org\/10.1212\/CON.0000000000000362","journal-title":"Continuum (Minneap Minn)"},{"key":"9150_CR2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.gaitpost.2017.11.024","volume":"60","author":"E Buckley","year":"2018","unstructured":"Buckley E, Mazz\u00e0 C, McNeill A (2018) A systematic review of the gait characteristics associated with cerebellar ataxia. Gait Posture 60:154\u2013163. https:\/\/doi.org\/10.1016\/j.gaitpost.2017.11.024","journal-title":"Gait Posture"},{"issue":"417","key":"9150_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117082","volume":"15","author":"SSO Scott","year":"2020","unstructured":"Scott SSO, Pedroso JL, Barsottini OGP, Fran\u00e7a-Junior MC, Braga-Neto P (2020) Natural history and epidemiology of the spinocerebellar ataxias: insights from the first description to nowadays. J Neurol Sci 15(417):117082. https:\/\/doi.org\/10.1016\/j.jns.2020.117082","journal-title":"J Neurol Sci"},{"issue":"8\u20139","key":"9150_CR4","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.neurol.2016.07.003","volume":"172","author":"C Tranchant","year":"2016","unstructured":"Tranchant C, Anheim M (2016) Movement disorders in mitochondrial diseases. Rev Neurol (Paris) 172(8\u20139):524\u2013529. https:\/\/doi.org\/10.1016\/j.neurol.2016.07.003","journal-title":"Rev Neurol (Paris)"},{"issue":"2","key":"9150_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/2514183X18785258","volume":"2","author":"F Pilotto","year":"2018","unstructured":"Pilotto F, Saxena S (2018) Epidemiology of inherited cerebellar ataxias and challenges in clinical research. Clin Transl Neurosci 2(2):25141831X8785258. https:\/\/doi.org\/10.1177\/2514183X18785258","journal-title":"Clin Transl Neurosci"},{"issue":"3","key":"9150_CR6","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000358801","volume":"42","author":"L Ruano","year":"2014","unstructured":"Ruano L, Melo C, Silva MC, Coutinho P (2014) The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology 42(3):174\u2013183. https:\/\/doi.org\/10.1159\/000358801","journal-title":"Neuroepidemiology"},{"key":"9150_CR7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/B978-0-444-64189-2.00014-7","volume":"155","author":"T Klockgether","year":"2018","unstructured":"Klockgether T (2018) Sporadic adult-onset ataxia. Handb Clin Neurol 155:217\u2013225. https:\/\/doi.org\/10.1016\/B978-0-444-64189-2.00014-7","journal-title":"Handb Clin Neurol"},{"issue":"10","key":"9150_CR8","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1080\/03007995.2022.2112870","volume":"38","author":"K Buesch","year":"2022","unstructured":"Buesch K, Zhang R (2022) A systematic review of disease prevalence, health-related quality of life, and economic outcomes associated with Friedreich\u2019s Ataxia. Curr Med Res Opin 38(10):1739\u20131749. https:\/\/doi.org\/10.1080\/03007995.2022.2112870","journal-title":"Curr Med Res Opin"},{"key":"9150_CR9","doi-asserted-by":"publisher","DOI":"10.12968\/bjon.2006.15.17.21908","author":"J Greenfield","year":"2006","unstructured":"Greenfield J, Treacy C, Giunti P (2006) Centres of excellence for the care of people with progressive ataxias. Br J Nurs. https:\/\/doi.org\/10.12968\/bjon.2006.15.17.21908","journal-title":"Br J Nurs"},{"key":"9150_CR10","doi-asserted-by":"publisher","DOI":"10.12968\/bjnn.2008.4.11.31698","author":"J Greenfield","year":"2008","unstructured":"Greenfield J, Treacy C, Giunti P (2008) Centres of excellence for the care of people with progressive ataxias. Br J Neurosci Nurs. https:\/\/doi.org\/10.12968\/bjnn.2008.4.11.31698","journal-title":"Br J Neurosci Nurs"},{"issue":"1","key":"9150_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1013-9","volume":"14","author":"R De Silva","year":"2019","unstructured":"De Silva R, Greenfield J, Cook A et al (2019) Guidelines on the diagnosis and management of the progressive ataxias. Orphanet J Rare Dis 14(1):51. https:\/\/doi.org\/10.1186\/s13023-019-1013-9","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"9150_CR12","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3325\/cmj.2019.60.156","volume":"60","author":"P Giunti","year":"2019","unstructured":"Giunti P et al (2019) Toward earlier diagnosis and treatment of rare neurological disorders: the value of coordinated care and specialist centers. Croat Med J 60(2):156","journal-title":"Croat Med J"},{"issue":"1","key":"9150_CR13","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s13023-014-0184-7","volume":"9","author":"LA Corben","year":"2014","unstructured":"Corben LA, Lynch D, Pandolfo M, Schulz JB, Delatycki MB, Clinical Management Guidelines Writing Group (2014) Consensus clinical management guidelines for Friedreich ataxia. Orphanet J Rare Dis 9(1):184. https:\/\/doi.org\/10.1186\/s13023-014-0184-7","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"9150_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/acn3.51266","volume":"8","author":"J Afonso Ribeiro","year":"2021","unstructured":"Afonso Ribeiro J, Simeoni S, De Min L et al (2021) Lower urinary tract and bowel dysfunction in spinocerebellar ataxias. Ann Clin Transl Neurol 8(2):321\u2013331. https:\/\/doi.org\/10.1002\/acn3.51266","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"9150_CR15","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13023-017-0709-y","volume":"12","author":"M Lad","year":"2017","unstructured":"Lad M, Parkinson MH, Rai M et al (2017) Urinary, bowel and sexual symptoms in a cohort of patients with Friedreich\u2019s ataxia. Orphanet J Rare Dis 12(1):158. https:\/\/doi.org\/10.1186\/s13023-017-0709-y","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"9150_CR16","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s12311-021-01236-9","volume":"20","author":"N Koohi","year":"2021","unstructured":"Koohi N, Thomas-Black G, Giunti P, Bamiou DE (2021) Auditory phenotypic variability in Friedreich\u2019s Ataxia patients. Cerebellum 20(4):497\u2013508. https:\/\/doi.org\/10.1007\/s12311-021-01236-9","journal-title":"Cerebellum"},{"key":"9150_CR17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1136\/practneurol-2018-002096","volume":"19","author":"RN De Silva","year":"2019","unstructured":"De Silva RN, Vallortigara J, Greenfield J et al (2019) Diagnosis and management of progressive ataxia in adults. Pract Neurol 19:196\u2013207","journal-title":"Pract Neurol"},{"issue":"2","key":"9150_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.molmed.2023.12.002","volume":"30","author":"F Pilotto","year":"2024","unstructured":"Pilotto F, Chellapandi DM, Puccio H (2024) Omaveloxolone: a groundbreaking milestone as the first FDA-approved drug for Friedreich ataxia. Trends Mol Med 30(2):117\u2013125. https:\/\/doi.org\/10.1016\/j.molmed.2023.12.002","journal-title":"Trends Mol Med"},{"key":"9150_CR19","unstructured":"European Medicine Agency, Science Medicines Health, Skyclarys. Skyclarys: EPAR \u2013 Medicine overview (2024). Available online (Accessed October 22nd, 2024). https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/skyclarys"},{"issue":"1","key":"9150_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-023-02907-y","volume":"18","author":"J Vallortigara","year":"2023","unstructured":"Vallortigara J, Greenfield J, Hunt B, Hoffman D, Reinhard C, Graessner H, Federico A, Quoidbach V, Morris S, Giunti P (2023) Patient pathways for rare diseases in Europe: ataxia as an example. Orphanet J Rare Dis 18(1):328. https:\/\/doi.org\/10.1186\/s13023-023-02907-y","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"9150_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-023-02971-4","volume":"18","author":"S Morris","year":"2023","unstructured":"Morris S, Vallortigara J, Greenfield J, Hunt B, Hoffman D, Reinhard C, Graessner H, Federico A, Quoidbach V, Giunti P (2023) Impact of specialist ataxia centres on health service resource utilisation and costs across Europe: cross-sectional survey. Orphanet J Rare Dis 18(1):382. https:\/\/doi.org\/10.1186\/s13023-023-02971-4","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"9150_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-084865","volume":"14","author":"J Vallortigara","year":"2024","unstructured":"Vallortigara J, Greenfield J, Hunt B, Hoffman D, Booth S, Morris S, Giunti P (2024) Comparison of specialist ataxia centres with non-specialist services in terms of treatment, care, health services resource utilisation and costs in the UK using patient-reported data. BMJ Open 14(9):e084865. https:\/\/doi.org\/10.1136\/bmjopen-2024-084865","journal-title":"BMJ Open"},{"issue":"3","key":"9150_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2025.e42121","volume":"11","author":"J Vallortigara","year":"2025","unstructured":"Vallortigara J, Greenfield J, Hunt B, Graessner H, Reinhard C, Nadke A, Schuman BJ, Hoffman D, Morris S, Giunti P (2025) Comparison of specialist ataxia centres with non-specialist services in terms of care access and organisation, health services resource utilisation and costs in Germany using patient-reported data. Heliyon 11(3):e42121. https:\/\/doi.org\/10.1016\/j.heliyon.2025.e42121","journal-title":"Heliyon"},{"key":"9150_CR24","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s10198-020-01229-1","volume":"21","author":"J P\u00f6hlmann","year":"2020","unstructured":"P\u00f6hlmann J, Norrbacka K, Boye KS, Valentine WJ, Sapin H (2020) Costs and where to find them: identifying unit costs for health economic evaluations of diabetes in France, Germany and Italy. Eur J Health Econ 21:1179\u20131196. https:\/\/doi.org\/10.1007\/s10198-020-01229-1","journal-title":"Eur J Health Econ"},{"key":"9150_CR25","unstructured":"World Bank Group (2023) Inflation, consumer prices (annual %) - Italy, 1969. Available online (Accessed April 1st, 2025). https:\/\/data.worldbank.org\/indicator\/FP.CPI.TOTL.ZG?locations=IT"},{"key":"9150_CR26","unstructured":"Leaflet ATAXIA: WHAT\u2019S THAT? produced by The European Reference Network \u2013 Rare Neurological Diseases with the input of Ataxia UK. Available online (Accessed October 22nd, 2024). https:\/\/www.ern-rnd.eu\/wp-content\/uploads\/2021\/02\/General-ataxia-leaflet-_ERN-RND_2021.pdf"},{"key":"9150_CR27","unstructured":"Hedley, V. and Rodwell, C. (2019) Rare 2030 Knowledge Base Summary on Access to Healthcare for Rare Diseases. https:\/\/download2.eurordis.org\/rare2030\/Knowledge_Based_Summaries\/Access_to_Healthcare_for_Rare_Diseases.pdf"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09150-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09150-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09150-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T02:41:56Z","timestamp":1786588916000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-09150-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["9150"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-09150-w","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"4 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Consent was obtained online, with the act of submitting the survey considered as consent to take part in the study.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"638"}}